Fig. 2From: A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE studyMean amount of r-hFSH (IU) administered per oocyte retrieved for matched pairs of patients (n = 123) at risk of OHSS – primary analysis (all patients, irrespective of GnRH protocol) and sensitivity analysis (in patients receiving GnRH agonist)Back to article page